Synovial inflammation and bone metabolism
PRINCIPAL INVESTIGATORS
- Xavier Juanola Roura
- José Antonio Narváez García
- Joan Miguel Nolla Solé
- Jesús Rodríguez Moreno
- Montserrat Romera Baures
- Antonio Rozadilla Sacanell
CLINICAL RESEARCHERS
- Carmen Gómez Vaquero
- Carmen Moragues Pastor
- Itziar Oronoz Mitxelena
- José Miguel Ruiz Martín
- Lidia Valencia Muntalà
SCIENTIFIC SUPPORT
- Daniel Fontes Carame
Translational Medicine
Cardiovascular, Respiratory and Systemic Diseases and cellular aging
Scientific production
26
PAPERS
Average IF: 4,957
7
LED PAPERS
Average IF: 3,825
5 PUBLICATIONS IN FIRST QUARTILE
11 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Herrero Morant,A; Martin Varillas,JL; Castaneda,S; Maiz,O; Sanchez,J; Ortego,N; Raya,E et al, Biologic therapy in refractory neurobehcet’s disease: a multicentre study of 41 patients and literature review, Rheumatology (Oxford), 2022;61(11):4427-4436, doi:10.1093/rheumatology/keac097
- Morales Ivorra,I; Narváez,J; Gómez Vaquero,C; Moragues,C; Nolla,JM; Narváez,JA; Marín López,MA, Assessment of inflammation in patients with rheumatoid arthritis using thermography and machine learning: a fast and automated technique., RMD Open, 2022;8(2):doi:10.1136/rmdopen-2022-002458
- Morales Ivorra,I; Narvaez,J;Gomez Vaquero,C; Moragues,C; Nolla,JM; Narvaez,JA; Marin Lopez,MA, A Thermographic Disease Activity Index for remote assessment of rheumatoid arthritis, RMD Open, 2022; 8(2): doi:10.1136/rmdopen-2022-002615
- Michelena,X;Lopez Medina,C;Erra,A;Juanola,X;Font Ugalde,P; Collantes,E; Marzo Ortega,H, Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry, RMD Open, 2022;8(2):doi:10.1136/rmdopen-2022-002513
- Llop,M; Moreno,M; Navarro Compan,V; Juanola,X; de Miguel,E; Almodovar,R; Quintana,EC et al, Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO, Arthritis Res Ther, 2022;24(1):30-30, doi:10.1186/s13075-021-02695-5
Research highlights
PROJECTS
2 Ongoing competitive projects
2 Started clinical trials
11 Ongoing clinical trials
1 Ongoing non competitive project
PUBLISHED WORKS
3 Clinical Guidelines
NETWORKS
RIER
Selected projects
- 21MAR007. Design of an integrative patients stratification approach for the systemic sclerosis management. Fundació La Marató de TV3. Budget: 143583. 2021-2024. PI: Narváez García, Javier.
- 18ACL007. ESTUDIO DE FASE 4 ABIERTO, RANDOMIZADO CONTROLADO QUE COMPARAR LA EFICACIA DE LA INTRODUCCIÓN DE ADALIMUMBAB Y EL ESCALADO DE DOSIS DE METOTREXATO EN PACIENTES CON ARTRITIS PSIRIÁSICA (CONTROL). Budget: 47545. 2018- . PI: Ruiz Martín, José Miguel.
- 21PRC004. REGISPON-3: SEGUIMIENTO DEL REGISTRO ESPAÑOL DE ESPONDILOARTRITIS. ASPECTOS CLÍNICOS, TERAPÉUTICOS Y MOLECULARES. Budget: 30700. 2021- . PI: Juanola Roura, Xavier.
- 17FIS031. Red de Investigación en Inflamación y Enfermedades Reumáticas (RIER). Budget: 16500. 2017-2022. PI: Narváez García, Javier.
- 2022-018-1. PAUTAS DE TRATAMIENTO CON UPADACITINIB, CONSECUCIÓN DE LOS OBJETIVOS TERAPÉUTICOS Y MANTENIMIENTO DE LA RESPUESTA EN PACIENTES CON ARTRITIS REUMATOIDE DE MODERADA A GRAVE EN LA PRÁCTICA REAL (UPHOLD). AbbVie Spain, S.L.U. Budget: 9100. 2021- . PI: Ruiz Martín, José Miguel.